WATERTOWN, Mass., July 17, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the…Read More
Latest News EyePoint Pharmaceuticals Reports Inducement Grants Under Businessfortnight
